The Cure Sanfilippo Foundation is on track, with more than $1 million raised in a GoFundMe campaign, to support…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
At its first virtual investor event, biotech company Centogene set a bold mission: to cure 100 rare diseases…
To help patient advocacy leaders and their partners better understand how global health statistics codes — known as ICD codes…
Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual…
They aren’t even teenagers yet, but Connor Dobbyn’s closest friends are engaged in a a most serious effort — to…
From “getting messy” in a workshop to participating in an art class, supporters globally are marking MPS Awareness Week, observed…
The MPS Society will use a £195,000 (about $268,000) award from the National Lottery Community Fund to build…
Impassioned videos, including a new one about a 12-year-old who has Sanfilippo syndrome and his parents’ battle to save him,…
Rare Disease Day at NIH, organized by the National Institutes of Health (NIH) and taking place on March 1,…
For nearly two years, an Ohio couple shared the heartbreaking story of their young son’s diagnosis with Sanfilippo syndrome,…